Who
Daniel Hume
Director
Company insider
Files Form 4 as: Director, TG Therapeutics; Director, National Holdings; Director, Stemline Therapeutics.
In numbers
- Trades disclosed
- 32
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 3
- Companies where not an officer
- 3
- First trade
- 6 Jul 2016
- Last trade
- 11 Jun 2026
- Last filed
- 15 Jun 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 11 Jun 2026filed 15 Jun 2026 | TGTX TG Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —8,325 at $0.00 | filing |
| 11 Jun 2026filed 15 Jun 2026 | TGTX TG Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —8,325 at $0.00 | filing |
| 12 Jun 2025filed 16 Jun 2025 | TGTX TG TherapeuticsBiotechnology | SEC FORM 4 Code A | —14,718 at $0.00 | filing |
| 17 Mar 2025filed 18 Mar 2025 | TGTX TG TherapeuticsBiotechnology | SEC FORM 4 Code G | —62,459 at $0.00 | filing |
| 19 Jun 2024filed 20 Jun 2024 | TGTX TG TherapeuticsBiotechnology | SEC FORM 4 Code A | —22,250 at $0.00 | filing |
| 28 Sep 2023filed 29 Sep 2023 | TGTX TG TherapeuticsBiotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 20 Jul 2022filed 22 Jul 2022 | TGTX TG TherapeuticsBiotechnology | SEC FORM 4 Code A | —43,732 at $0.00 | filing |
| 18 Jun 2021filed 22 Jun 2021 | TGTX TG TherapeuticsBiotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 25 Feb 2021filed 25 Feb 2021 | National Holdingsoption or derivative | SEC FORM 4 Code D | $151K46,602 at $3.25 | filing |
| 25 Feb 2021filed 25 Feb 2021 | National Holdings | SEC FORM 4 Code U | $202K62,151 at $3.25 | filing |
| 22 Jun 2020filed 24 Jun 2020 | TGTX TG TherapeuticsBiotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 10 Jun 2020filed 10 Jun 2020 | Stemline Therapeutics | SEC FORM 4 Code U | —35,468 | filing |
| 2 Apr 2020filed 6 Apr 2020 | National Holdingsoption or derivative | SEC FORM 4 Code A | —32,680 at $0.00 | filing |
| 13 Feb 2020filed 14 Feb 2020 | National Holdingsoption or derivative | SEC FORM 4 Code M | —5,160 at $0.00 | filing |
| 13 Feb 2020filed 14 Feb 2020 | National Holdings | SEC FORM 4 Code M | —5,160 | filing |
| 12 Feb 2020filed 14 Feb 2020 | National Holdingsoption or derivative | SEC FORM 4 Code M | —25,000 at $0.00 | filing |
| 12 Feb 2020filed 14 Feb 2020 | National Holdingsoption or derivative | SEC FORM 4 Code M | —3,496 at $0.00 | filing |
| 12 Feb 2020filed 14 Feb 2020 | National Holdings | SEC FORM 4 Code M | —25,000 | filing |
| 12 Feb 2020filed 14 Feb 2020 | National Holdings | SEC FORM 4 Code M | —3,496 | filing |
| 17 Sep 2019filed 18 Sep 2019 | TGTX TG TherapeuticsBiotechnology | SEC FORM 4 Code A | —27,048 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.